Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,987
Sort by:
Anterior Uveitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Anterior Uveitis Key assessments Patient Segmentation in Anterior Uveitis Anterior Uveitis Risk & Burden Factors driving growth in a specific Anterior Uveitis patient population
January 2022
60 pages
Aplastic Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Aplastic Anemia Key assessments Patient Segmentation in Aplastic Anemia Aplastic Anemia Risk & Burden Factors driving growth in a specific Aplastic Anemia patient population
January 2022
60 pages
Aptiom - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Aptiom API intelligence over Aptiom and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Aristada - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Aristada API intelligence over Aristada and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Aspergillosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Aspergillosis Key assessments Patient Segmentation in Aspergillosis Aspergillosis Risk & Burden Factors driving growth in a specific Aspergillosis patient population
January 2022
60 pages
Autism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Autism Key assessments Patient Segmentation in Autism Autism Risk & Burden Factors driving growth in a specific Autism patient population
January 2022
60 pages
Parkinson's Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Autism Therapeutic Approaches in Autism Autism Pipeline Analysis Autism Market Size and Trends Autism Market Opportunities Impact of upcoming Therapies in Autism Autism Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Autism ...
January 2022
200 pages
Axiron - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Axiron API intelligence over Axiron and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Azilect - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Azilect API intelligence over Azilect and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Azor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Azor API intelligence over Azor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Bacteremia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacteremia Key assessments Patient Segmentation in Bacteremia Bacteremia Risk & Burden Factors driving growth in a specific Bacteremia patient population
January 2022
60 pages
Bacterial (Pyogenic) Meningitis - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial (Pyogenic) Meningitis Key assessments Patient Segmentation in Bacterial (Pyogenic) Meningitis Bacterial (Pyogenic) Meningitis Risk & Burden Factors driving growth in a specific Bacterial (Pyogenic) Meningitis patient ...
January 2022
60 pages
Bacterial Conjunctivitis - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial Conjunctivitis Key assessments Patient Segmentation in Bacterial Conjunctivitis Bacterial Conjunctivitis Risk & Burden Factors driving growth in a specific Bacterial Conjunctivitis patient population
January 2022
60 pages
Bacterial Pneumonia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial Pneumonia Key assessments Patient Segmentation in Bacterial Pneumonia Bacterial Pneumonia Risk & Burden Factors driving growth in a specific Bacterial Pneumonia patient population
January 2022
60 pages
Bacterial Vaginosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial Vaginosis Key assessments Patient Segmentation in Bacterial Vaginosis Bacterial Vaginosis Risk & Burden Factors driving growth in a specific Bacterial Vaginosis patient population
January 2022
60 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) - Epidemiology Forecast to 2032
US$ 3,950.00
... population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Basal Cell Carcinoma (Basal Cell Epithelioma) Key assessments Patient Segmentation in Basal Cell Carcinoma (Basal Cell Epithelioma) Basal Cell Carcinoma (Basal Cell Epithelioma) Risk & Burden Factors driving growth in a specific Basal Cell ...
January 2022
60 pages
B-Cell Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in B-Cell Chronic Lymphocytic Leukemia Key assessments Patient Segmentation in B-Cell Chronic Lymphocytic Leukemia B-Cell Chronic Lymphocytic Leukemia Risk & Burden Factors driving growth in a specific B-Cell Chronic Lymphocytic Leukemia patient population
January 2022
60 pages
B-Cell Lymphomas - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in B-Cell Lymphomas Key assessments Patient Segmentation in B-Cell Lymphomas B-Cell Lymphomas Risk & Burden Factors driving growth in a specific B-Cell Lymphomas patient population
January 2022
60 pages
Behcet's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Behcet's Disease Key assessments Patient Segmentation in Behcet's Disease Behcet's Disease Risk & Burden Factors driving growth in a specific Behcet's Disease patient population
January 2022
60 pages
Beleodaq - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Beleodaq API intelligence over Beleodaq and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
BeneFIX - API Insight, 2022
US$ 500.00
... patent expiry details with respect to BeneFIX API intelligence over BeneFIX and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Biliary Tumor - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Biliary Tumor Key assessments Patient Segmentation in Biliary Tumor Biliary Tumor Risk & Burden Factors driving growth in a specific Biliary Tumor patient population
January 2022
60 pages
Binge (Eating) Disorders - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Binge (Eating) Disorders Key assessments Patient Segmentation in Binge (Eating) Disorders Binge (Eating) Disorders Risk & Burden Factors driving growth in a specific Binge (Eating) Disorders patient population
January 2022
60 pages
Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Bipolar Disorder (Manic Depression) Key assessments Patient Segmentation in Bipolar Disorder (Manic Depression) Bipolar Disorder (Manic Depression) Risk & Burden Factors driving growth in a specific Bipolar Disorder (Manic Depression) patient population
January 2022
60 pages
Blepharitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Blepharitis Key assessments Patient Segmentation in Blepharitis Blepharitis Risk & Burden Factors driving growth in a specific Blepharitis patient population
January 2022
60 pages
Bone Metastasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bone Metastasis Key assessments Patient Segmentation in Bone Metastasis Bone Metastasis Risk & Burden Factors driving growth in a specific Bone Metastasis patient population
January 2022
60 pages
Botox - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Botox API intelligence over Botox and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Breo Ellipta - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Breo Ellipta API intelligence over Breo Ellipta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Byetta - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Byetta API intelligence over Byetta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Celiac Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Celiac Disease Key assessments Patient Segmentation in Celiac Disease Celiac Disease Risk & Burden Factors driving growth in a specific Celiac Disease patient population
January 2022
60 pages
Cervical Cancer Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cervical Cancer Key assessments Patient Segmentation in Cervical Cancer Cervical Cancer Risk & Burden Factors driving growth in a specific Cervical Cancer patient population
January 2022
60 pages
Chemotherapy Induced Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chemotherapy Induced Anemia Key assessments Patient Segmentation in Chemotherapy Induced Anemia Chemotherapy Induced Anemia Risk & Burden Factors driving growth in a specific Chemotherapy Induced Anemia patient population
January 2022
60 pages
Chemotherapy Induced Neutropenia - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chemotherapy Induced Neutropenia Key assessments Patient Segmentation in Chemotherapy Induced Neutropenia Chemotherapy Induced Neutropenia Risk & Burden Factors driving growth in a specific Chemotherapy Induced Neutropenia patient ...
January 2022
60 pages
Cholbam - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Cholbam API intelligence over Cholbam and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Choroidal Neovascularization - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Choroidal Neovascularization Key assessments Patient Segmentation in Choroidal Neovascularization Choroidal Neovascularization Risk & Burden Factors driving growth in a specific Choroidal Neovascularization patient population
January 2022
60 pages
Chronic Bronchitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Bronchitis Key assessments Patient Segmentation in Chronic Bronchitis Chronic Bronchitis Risk & Burden Factors driving growth in a specific Chronic Bronchitis patient population
January 2022
60 pages
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Key assessments Patient Segmentation in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Risk & Burden Factors ...
January 2022
60 pages
Chronic Kidney Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Kidney Disease (Chronic Renal Failure) Key assessments Patient Segmentation in Chronic Kidney Disease (Chronic Renal Failure) Chronic Kidney Disease (Chronic Renal Failure) Risk & Burden Factors driving growth ...
January 2022
60 pages
Chronic Liver Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Liver Disease Key assessments Patient Segmentation in Chronic Liver Disease Chronic Liver Disease Risk & Burden Factors driving growth in a specific Chronic Liver Disease patient population
January 2022
60 pages
Chronic Plaque Psoriasis - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Plaque Psoriasis Key assessments Patient Segmentation in Chronic Plaque Psoriasis Chronic Plaque Psoriasis Risk & Burden Factors driving growth in a specific Chronic Plaque Psoriasis patient population
January 2022
60 pages
Condyloma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Condyloma Key assessments Patient Segmentation in Condyloma Condyloma Risk & Burden Factors driving growth in a specific Condyloma patient population
January 2022
60 pages
Corlanor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Corlanor API intelligence over Corlanor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Crestor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Crestor API intelligence over Crestor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Cubicin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Cubicin API intelligence over Cubicin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Cushing's Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cushing's Syndrome Key assessments Patient Segmentation in Cushing's Syndrome Cushing's Syndrome Risk & Burden Factors driving growth in a specific Cushing's Syndrome patient population
January 2022
60 pages
Cutaneous Squamous cell Carcinoma (CsCC) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Cutaneous Squamous cell Carcinoma (CsCC) Key assessments Patient Segmentation in Cutaneous Squamous cell Carcinoma (CsCC) Cutaneous Squamous cell Carcinoma (CsCC) Risk & Burden Factors driving growth in a specific Cutaneous Squamous cell Carcinoma (CsCC) patient population ...
January 2022
60 pages
Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cutaneous T-Cell Lymphoma(CTCL) Key assessments Patient Segmentation in Cutaneous T-Cell Lymphoma(CTCL) Cutaneous T-Cell Lymphoma(CTCL) Risk & Burden Factors driving growth in a specific Cutaneous T-Cell Lymphoma(CTCL) patient ...
January 2022
60 pages
Cystitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cystitis Key assessments Patient Segmentation in Cystitis Cystitis Risk & Burden Factors driving growth in a specific Cystitis patient population
January 2022
60 pages
